Evidence map›Paper›PMID 32475168›Full record

ArticleJournal of diabetes science and technology2020

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.

Antonio Ceriello, Oliver Schnell

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Healthcare outcomes in patients with HIV infection at a tertiary hospital during the COVID-19 pandemic.Enfermedades infecciosas y microbiologia clinica (English ed.) · 2023
    Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antonio CerielloIRCCS MultiMedica, Milan, Italy.
Oliver SchnellForschergruppe Diabetes e.V.at Munich Helmholtz Centre Munich, Germany.ORCID https://orcid.org/0000-0003-4968-2367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusPandemicsAngiotensin-Converting Enzyme 2Blood GlucoseCardiovascular DiseasesComorbidityCoronavirus InfectionsCOVID-19Diabetes ComplicationsDiabetes MellitusDiabetic CardiomyopathiesHumansHypoglycemic AgentsIntensive Care UnitsPeptidyl-Dipeptidase APneumonia, ViralACE2 protein, humanAngiotensin-Converting Enzyme 2Blood GlucoseHypoglycemic AgentsPeptidyl-Dipeptidase Acontinuous glucose monitoringCOVID-19diabetesglucose variabilityintensive care unitSARS -CoV-2telemedicine

Identifiers

PMID32475168
PMCPMC7673148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.